Unexpectedly low drug exposures among Ugandan patients with TB and HIV receiving high-dose rifampicin. Kengo A, Gausi K, Nabisere R, Musaazi J, et al. Antimicrob Agents Chemother 2023 Oct 18:e0043123. doi: 10.1128/aac.00431.

Read + Share

Amedeo Smart

Independent Medical Education

Kengo A, Gausi K, Nabisere R, Musaazi J, et al. Unexpectedly low drug exposures among Ugandan patients with TB and HIV receiving high-dose rifampicin. Antimicrob Agents Chemother 2023 Oct 18:e0043123. doi: 10.1128/aac.00431.
PMID: 37850737